{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Natraj Proteins Ltd
Why is Natraj Proteins Ltd falling/rising?
On 07-Jan, Natraj Proteins Ltd witnessed a notable rise in its share price, climbing 2.89% to ₹32.73, outperforming its sector and the broader market despite a challenging longer-term performance record.
Natraj Proteins Ltd Stock Hits 52-Week Low Amidst Continued Underperformance
Natraj Proteins Ltd, a player in the edible oil sector, witnessed its stock price decline sharply to a new 52-week low of Rs.29 today, marking a significant milestone in its recent performance trajectory. The stock’s fall comes amid persistent challenges reflected in its financial metrics and market positioning, with the share price underperforming both its sector and broader market indices.
Natraj Proteins Ltd Falls to 52-Week Low Amidst Continued Underperformance
Natraj Proteins Ltd, a player in the edible oil sector, recorded a fresh 52-week low of Rs.30.15 today, marking a significant decline in its stock price amid ongoing challenges reflected in its financial performance and market positioning.
Natraj Proteins Ltd is Rated Strong Sell
Natraj Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 31 July 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 26 December 2025, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Natraj Proteins Stock Falls to 52-Week Low of Rs.31.3 Amidst Continued Underperformance
Natraj Proteins has reached a new 52-week low of Rs.31.3, marking a significant price level for the edible oil company as it continues to trade below all major moving averages despite recent short-term gains.
Natraj Proteins Stock Falls to 52-Week Low of Rs.32 Amidst Continued Downtrend
Natraj Proteins has reached a new 52-week low of Rs.32, marking a significant decline in its stock price amid ongoing downward momentum. The edible oil company’s shares have underperformed both its sector and broader market indices, reflecting persistent pressures on its financial performance and valuation.
Natraj Proteins Sees Revision in Market Evaluation Amidst Challenging Financials
Natraj Proteins, a microcap player in the edible oil sector, has experienced a notable revision in its market evaluation, reflecting ongoing challenges in its financial and technical performance. The stock has faced persistent downward pressure, with recent assessment changes highlighting concerns across multiple analytical parameters.
Why is Natraj Proteins falling/rising?
As of 18-Nov, Natraj Proteins Ltd is facing a decline in stock price, currently at 37.50, down 1.32% and underperforming against the Sensex, which has gained 8.36% year-to-date. The stock has fallen for four consecutive days and is trading below all key moving averages, indicating significant challenges in maintaining investor confidence.
Natraj Proteins Q2 FY26: Mounting Losses Deepen as Operating Margins Turn Severely Negative
Natraj Proteins Ltd., a micro-cap edible oil manufacturer with a market capitalisation of ₹16.00 crores, reported a widening quarterly loss in Q2 FY26, posting a net loss of ₹1.65 crores compared to a loss of ₹1.21 crores in Q1 FY26. The sequential deterioration of 36.36% underscores the mounting operational challenges facing the Madhya Pradesh-based company, which has struggled to maintain profitability despite modest revenue growth. Year-on-year, the loss widened from ₹1.01 crores in Q2 FY25, representing a 63.37% deterioration in bottom-line performance.
Natraj Proteins Faces Financial Challenges Amidst Operational Efficiency Gains
Natraj Proteins, a microcap in the edible oil sector, reported a negative financial performance for the quarter ending September 2025, with declining net sales and low quarterly PBDIT. Despite achieving its highest operating cash flow, the company faces significant challenges, reflected in its stock performance compared to the Sensex.
Is Natraj Proteins overvalued or undervalued?
As of November 17, 2025, Natraj Proteins is considered undervalued with a valuation grade shift to attractive, featuring a PE ratio of -9.07 and an EV to EBITDA of 34.42, significantly lower than peers like Gokul Agro and Guj. Ambuja Exp, despite a year-to-date return of -14.80% compared to the Sensex's 8.72%, indicating potential for recovery and growth.
How has been the historical performance of Natraj Proteins?
Natraj Proteins has experienced significant fluctuations in financial performance, with declining net sales and operating income, but improved cash flow from operations. Despite a positive operating profit in Mar'25, the company continues to face challenges with negative profits before and after tax.
Is Natraj Proteins overvalued or undervalued?
As of October 16, 2025, Natraj Proteins is considered very expensive and overvalued with a PE ratio of -16.45 and an EV to EBITDA of 25.34, significantly underperforming its peers and the Sensex, which highlights its deteriorating valuation outlook.
Is Natraj Proteins overvalued or undervalued?
As of October 14, 2025, Natraj Proteins is considered overvalued with a valuation grade of "expensive," highlighted by a negative PE ratio of -16.48 and an underperformance of -8.30% year-to-date compared to the Sensex's 4.98%, while peers like Gokul Agro and Guj. Ambuja Exp show fair and attractive valuations, respectively.
Why is Natraj Proteins falling/rising?
As of 09-Oct, Natraj Proteins Ltd's stock price is Rs 40.69, up 2.88% today, with significant volatility. While it has outperformed its sector recently, its year-to-date performance lags behind the Sensex, indicating a mixed outlook.
Why is Natraj Proteins falling/rising?
As of 07-Oct, Natraj Proteins Ltd is currently priced at Rs 41.81, reflecting a short-term increase despite a year-to-date decline of 6.26%. The stock shows bullish sentiment with trading above moving averages, but decreased investor participation and underperformance against the Sensex raise concerns about the sustainability of its recent gains.
Is Natraj Proteins overvalued or undervalued?
As of October 1, 2025, Natraj Proteins is considered very expensive and overvalued, with a PE ratio of -14.61 and an EV to EBITDA of 24.88, significantly underperforming its peers and the market.
Natraj Proteins Experiences Valuation Grade Change Amidst Financial Challenges in Edible Oil Sector
Natraj Proteins, a microcap in the edible oil sector, has experienced a valuation adjustment, revealing significant challenges in profitability and operational performance. Its financial metrics, including a negative PE ratio and low return on capital, contrast sharply with more favorable valuations of its peers, highlighting competitive difficulties.
Is Natraj Proteins overvalued or undervalued?
As of October 1, 2025, Natraj Proteins is considered very expensive and overvalued, with a negative PE ratio of -14.61 and significant financial distress, underperforming against peers and the Sensex.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
